J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 48(8); 2005 > Article
Ahn: Is Diabetes in Korea Different?

Abstract

The prevalence of diabetes mellitus(DM) is increasing in Korea and is estimated at 7~8%. This high prevalence is most likely the result of a complex interaction between genetic and environmental factors. The lifestyle and diet of the Korean population have changed significantly during the last several decades. In general, the Koreans have become more sedentary and they consume westernized diet. In addition to the increase of prevalence, the clinical characteristics of DM in Korea are somewhat different from those in Western countries. The incidence rate of type 1 DM in Korea is one of the lowest reported in the world. There are many patients with atypical type 1 or type 2 DM, initially classified into type 2 DM but requiring insulin eventually. There are many patients with non-obese type 2 DM, and many of them lose weight significantly during the course of disease. In addition, some patients with type 2 DM have autoantibodies to the beta cell-specific antigen. The defect in insulin secretion is prominent in non-obese subjects with impaired glucose tolerance or early phase of type 2 DM. The Korean patients with type 2 DM have a markedly decreased beta cell mass. The impaired insulin secretion may play a role in the pathogenesis of non-obese type 2 DM in Korea. Of note, similar features are also observed in Japanese patients. Unfortunately, there are few studies that evaluated the pathogenesis and clinical characteristics of Korean patients with DM, particularly in a cohort-based prospective manner.

References

1. Ko Kw, Sw Yang, Nh Cho. The incidence of IDDM in Seoul from 1985 to 1988. Diabetes Care 1994;17:1473-1475.

2. Lee Hk, Ys Oh, Yh Chung, Hj Yoo, Sh Shin, Yk Choi, et al. Epidemiological characteristics of ketoacidosis among Korean diabetic patients. J Korean Med Sci 1987;2:7-11.

5. Lee Ku, Kim Sw, Park Jy, Ko Ks, Rhee Bd, Min Hk. Clinical heterogeneity of insulin dependent diabetes mellitus in Korea. Diabetes Res Clin Pract 1995;27:159-162.

6. Park Ys, Kawasaki E, Kelemen K, Yu L, Schiller Mr, Hutton Jc, et al. Humoral autoreactivity to an alternatively spliced variant of ICA512/IA-2 in Type I diabetes. Diabetologia 2000;43:1293-1301.

8. Buzzetti R, Nistico L, Osborn J, Giovannini C, Chersi A, Sorrentino R. HLA-DQA1 and DQB1 gene polymorphisms in type I diabetic patients from central Italy and their use for risk prediction. Diabetes 1993;42:1173-1178.

9. Kida K, Mimura G, Kobayashi T, Nakamura K, Sonoda S, Tsuji K, et al. Immunogenetic heterogeneity in type 1 (insulin-dependent) diabetes among Japanese HLA antigens and organ-specific autoantibodies. Diabetologia 1989;32:34-39.

10. Sugihara S, Sakamaki T, Konda S, Murata A, Wataki K, Niimi H, et al. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes 1997;46:1893-1897.

19. In: Rifkin H Pjd, editor. Diabetes Mellitus; Theory and Practice 1990;New York: Elsevier.

20. Zimmet P, Dowse G, Finch C, Serjeantson S, King H. The epidemiology and natural history of NIDDM-lessons from the South Pacific. Diabetes Metab Rev 1990;6:91-124.

21. Saad Mf, Knowler Wc, Pettitt Dj, Nelson Rg, Charles Ma, Bennett Ph. A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991;90:229-235.

22. Warram Jh, Martin Bc, Krolewski As, Soeldner Js, Kahn Cr. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990;113:909-915.

23. Gulli G, Ferrannini E, Stern M, Haffner S, Defronzo Ra. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992;41:1575-1586.

24. Martin Bc, Warram Jh, Krolewski As, Bergman Rn, Soeldner Js, Kah Cr. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992;340:925-929.

25. Pimenta W, Mitrakou A, Jensen T, Yki-Jarvinen H, Daily G, Gerich J. Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. Diabet Med 1996;13:9 Suppl 6. 33-36.

26. Yoneda H, Ikegami H, Yamamoto Y, Yamato E, Cha T, Ogihara T, et al. Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 1992;15:1517-1521.

27. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Tominaga Y, et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 1997;20:1562-1568.

28. Doi K, Taniguchi A, Nakai Y, Kawamura H, Higaki Y, Fukushima M, et al. Decreased glucose effectiveness but not insulin resistance in glucose-tolerant offspring of Japanese non-insulin-dependent diabetic patients: a minimal-model analysis. Metabolism 1997;46:880-883.

33. Yoon Kh, Ko Sh, Cho Jh, Lee Jm, Ahn Yb, Bonner-Weir S, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003;88:2300-2308.

36. Reaven Gm, Chen Yd, Hollenbeck Cb, Sheu Wh, Ostrega D, Polonsky Ks. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993;76:44-48.

38. Zimmet Pz, Tuomi T, Mackay Ir, Rowley Mj, Knowles W, Lang Da, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994;11:299-303.

39. Nakanishi S, Okubo M, Yoneda M, Jitsuiki K, Yamane K, Kohno N. A comparison between Japanese-Americans living in Hawaii and Los Angeles and native Japanese: the impact of lifestyle westernization on diabetes mellitus. Biomed Pharmacother 2004;58:571-577.

Table 1
jkma-48-707-i001-l.jpg
Table 2
jkma-48-707-i002-l.jpg


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next